Eric Siemers
CIK 1866239 · View on SEC EDGAR ↗
First SEC filing: June 30, 2021 · Latest: June 30, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 17, 2023 | ABOS | A | 120,200 | — | — | 120,200 Direct | — | Acquired | (price as of 2026-08-19) |
| Jan. 17, 2023 | ABOS | A | 26,700 | — | — | 26,700 Direct | — | Acquired | (price as of 2026-08-19) |
| Jan. 19, 2022 | ABOS | A | 90,000 | — | — | 90,000 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 17, 2023 | ABOS | Employee Stock Option (right to buy) | Common Stock (120,200) | $6.11 | Jan. 16, 2033 | 120,200 | Acquired |
| Jan. 19, 2022 | ABOS | Employee Stock Option (right to buy) | Common Stock (90,000) | $5.19 | Jan. 19, 2032 | 90,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ABOS
M.D. Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $336,159 | — | — | — | $124,283 | — | $200 | $637,906 |
| 2020 | $180,000 | $57,600 | — | — | — | — | — | $237,600 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.